The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Vali-dation Study in ABCSG Trial 8.

Filipits, M; Rudas, M; Kainz, V; Singer, CF; Fitzal, F; Bago-Horvath, Z; Greil, R; Balic, M; Regitnig, P; Halper, S; Hulla, W; Egle, D; Barron, S; Loughman, T; OxxxLeary, D; Gallagher, WM; Hlauschek, D; Gnant, M; Dubsky, P.

Clin Cancer Res. 2021 Nov 1;27(21):5931-5938. doi: 10.1158/1078-0432.CCR-21-1023. Epub 2021 Aug 11.

https://pubmed.ncbi.nlm.nih.gov/34380638